drugset / Trial / NCT03012646
Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, single-arm trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pre-capillary pulmonary hypertension (PH) associated with Chronic Obstructive Pulmonary Disease (COPD).
Timeline
- Start
- 2017-04
- Primary completion
- 2019-04
- Completion
- 2019-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 6 ug | Inhaled |